The trademark Dolosine was filed by Infectopharm Arzneimittel und Consilium GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 13, 2020, and received one opposition filed on October 13, 2020 by Sanofi-Aventis Deutschland GmbH on Likelihood of confusion. the opponent was represented by ELZABURU, S.L.P. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 13, 2020
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for treating sports injuries
Pharmaceutical preparations for the treatment of gout
Pharmaceutical preparations for treating arthritis
Pharmaceutical preparations for treating rheumatological diseases
Analgesics
Dysmenorrhea treatment preparations
Anti-inflammatories
Pharmaceutical preparations for the treatment of inflammatory disorders
Pharmaceutical preparations for the treatment of inflammatory diseases
Pharmaceutical preparations and substances with anti-inflammatory properties
Non-steroidal anti-inflammatory drugs
Pharmaceutical preparations for the treatment of musculo-skeletal disorders.